Cangene bioPharma
1111 S. Paca Street
Baltimore
Maryland
21230
U.S.A.
Phone:
800-441-4225
Fax:
n/a
|
Cangene bioPharma performs clinical manufacturing for all regulatory phases. Contracting with Cangene bioPharma or clinical manufacturing has a number of advantages:
1. Because clinical drug substances are frequently expensive and difficult to obtain in quantity, Cangene bioPharma has systems designed to minimize losses, ensuring customers get the maximum amount of finished product possible.
2. Cangene bioPharma has a large selection of pre-qualified vials, stoppers and syringes. Choosing one of the Cangene bioPharma pre-qualified combinations can reduce the time from project initiation to production to two months in most cases.
3. Cangene bioPharma can fill liquid or lyophilized products in vial sizes from 3 to 100 cc and most major syringe sizes.
4. Cangene bioPharma has commercial scale manufacturing and a regulatory profile including approvals by regulatory agencies in multiple countries, allowing for growth and scale-up opportunities as your product progresses through to regulatory approval and commercial distribution.
For more information, please visit: http://www.cangenebiopharma.com/
Email:
info@cangenebiopharma.com
Ownership:
Subsidiary
Web Site:
Cangene bioPharma (Formerly Known as Chesapeake Biological Laboratories, Inc. (CBL))
Employees:
Symbol:
|